105 related articles for article (PubMed ID: 4716875)
1. Thymus recovery in tumour-bearing rats after tumour removal.
Toma V; Simu G
Oncology; 1973; 27(4):290-3. PubMed ID: 4716875
[No Abstract] [Full Text] [Related]
2. Dynamics of nucleic acids and total proteins in thymus of Walker carcinosarcoma bearing rats.
Toma V; Giurgea R
Arch Geschwulstforsch; 1976; 46(4):271-5. PubMed ID: 1086083
[TBL] [Abstract][Full Text] [Related]
3. [Implantation of the Walker carcinoma into the thymus gland].
Ertl N
Arch Geschwulstforsch; 1968; 31(2):147-53. PubMed ID: 5674795
[No Abstract] [Full Text] [Related]
4. Acceptance of Walker 256 carcinosarcoma by C57BL-6 mice treated with rabbit anti-mouse-thymus serum.
Kubista TP; Shorter RG; Hallenbeck GA
Cancer Res; 1967 Nov; 27(11):2072-6. PubMed ID: 6073502
[No Abstract] [Full Text] [Related]
5. Restoration of immunologic competence of neonatally thymectomized mice by thymic grafts.
Hallenbeck GA; Kubista TP; Shorter RG
Rev Surg; 1970; 27(1):59. PubMed ID: 5416524
[No Abstract] [Full Text] [Related]
6. The influence of age on organ-size changes due to tumour growth in rats.
Katona E
Growth; 1972 Mar; 36(1):35-43. PubMed ID: 4336245
[No Abstract] [Full Text] [Related]
7. Supression of species resistance in mice to rat tumor (Walker 256 carcinosarcoma) by rat thymus antiserum.
Anigstein L; Anigstein DM; Rennels EG
Tex Rep Biol Med; 1967; 25(2):214-22. PubMed ID: 6035439
[No Abstract] [Full Text] [Related]
8. Thymus involution in tumour-bearing hosts: mechanisms and possible significance.
Kiricuţă J; Simu G; Toma V
Arch Geschwulstforsch; 1970; 35(1):6-12. PubMed ID: 4997884
[No Abstract] [Full Text] [Related]
9. Control of food intake during growth of a Walker 256 carcinosarcoma.
Morrison SD
Cancer Res; 1973 Mar; 33(3):526-8. PubMed ID: 4689901
[No Abstract] [Full Text] [Related]
10. [The influence of light and darkness on male and female rats with Walker carcinosarcoma].
Tessmann D; Göcke H; Salditt G
Arch Geschwulstforsch; 1972; 39(4):300-3. PubMed ID: 5069159
[No Abstract] [Full Text] [Related]
11. Effects of various dietary fatty acids on enzyme activities of carbohydrate and glutamine metabolism and the metabolic response of lymphocytes and macrophages during Walker-256 ascites cell tumour growth in rats.
Rosa LF; Guimaraes AR; Safi DA; Curi R; Williams JF
Biochem Mol Biol Int; 1993 Jan; 29(1):33-45. PubMed ID: 8490566
[TBL] [Abstract][Full Text] [Related]
12. Effect of enzymatic removal of cell surface sialic acid on the adherence of Walker 256 tumor cells to mesothelial membrane.
Cormack D
Cancer Res; 1970 May; 30(5):1459-66. PubMed ID: 5426949
[No Abstract] [Full Text] [Related]
13. Changes in the opsonin and cellular influences on phagocytosis during the growth of transplantable tumors.
Kampschmidt RF; Pulliam LA
J Reticuloendothel Soc; 1972 Jan; 11(1):1-10. PubMed ID: 5060134
[No Abstract] [Full Text] [Related]
14. The retention of circulating Walker-256 cells by Walker-256 tumours.
Weiss L
Med Biol; 1978 Dec; 56(6):398-402. PubMed ID: 732370
[TBL] [Abstract][Full Text] [Related]
15. Suppression of the tumour transplantation immunity by the local graft-versus-host reaction.
Medzihradský J
Neoplasma; 1967; 14(4):369-75. PubMed ID: 6063011
[No Abstract] [Full Text] [Related]
16. Modification of tumor homograft immunity during the graft-versus-host reaction.
Medzihradský J
Neoplasma; 1966; 13(2):223-6. PubMed ID: 5911878
[No Abstract] [Full Text] [Related]
17. Adrenal influence on the metastases of 256 Walker carcinosarcoma intratesticulary grafts.
Zimel H; Macrineanu A
Neoplasma; 1970; 17(4):349-54. PubMed ID: 5506442
[No Abstract] [Full Text] [Related]
18. [On defined tumor-tolerant and tumor-resistant strains of CFN rats. (Genetic and immunobiological problems in the transplantation of Walker-256 carcinosarcoma in various homologous hosts)].
Lehmann FE; Meyer V
Arch Julius Klaus Stift Vererbungsforsch Sozialanthropol Rassenhyg; 1963; 38(3-4):242-52. PubMed ID: 5899906
[No Abstract] [Full Text] [Related]
19. A morphological and quantitative study of tumour blood flow during growth and immune rejection.
Oikawa M; Milne EN
Tohoku J Exp Med; 1974 Apr; 112(4):325-38. PubMed ID: 4604012
[No Abstract] [Full Text] [Related]
20. Stimulation of antibody formation and inhibition of 256 Walker carcinosarcoma development in rats treated with low-molecular-weight thymic polypeptides (TP2).
Milcu SM; Boeru V; Prahoveanu E; Zimel A; Ghinea E; Petrescu A
Endocrinologie; 1979; 17(1):23-8. PubMed ID: 432520
[No Abstract] [Full Text] [Related]
[Next] [New Search]
